# ADJUVANT COMPARISON AND CHARACTERIZATION - Influenza

> **NIH NIH N01** · UNIVERSITY OF CALIFORNIA-IRVINE · 2023 · $550,000

## Abstract

The goal of the Adjuvant Comparison and Characterization (ACC) program is to support side-by-side comparison of adjuvants in combination with clinically relevant vaccine/antigen platforms, and to establish both systemic and tissue-specific immunological profiles (“immune fingerprints”) of adjuvants that work through different mechanisms in the context of Influenza (flu), Chlamydia muridarum (Cm), and Coxiella burnetii (Cb).

## Key facts

- **NIH application ID:** 10934703
- **Project number:** 75N93022C00054-P00002-9999-3
- **Recipient organization:** UNIVERSITY OF CALIFORNIA-IRVINE
- **Principal Investigator:** PHILIP FELGNER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $550,000
- **Award type:** —
- **Project period:** 2022-09-01 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10934703

## Citation

> US National Institutes of Health, RePORTER application 10934703, ADJUVANT COMPARISON AND CHARACTERIZATION - Influenza (75N93022C00054-P00002-9999-3). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10934703. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*